Head to head
Molina Healthcare vs UnitedHealth
Side-by-side on the measures that matter, with a plain-English read. Full detail: MOH · UNH
MOH
Molina Healthcare
198.39-2.43%
1-year price shape — +47% over the period
Quant Rating C · 84/100
vs
UNH
UnitedHealth
339.85+2.84%
1-year price shape — +11% over the period
Quant Rating D · 55/100
1-year performance, rebased to 100
UnitedHealth edges it on the scoreable measures. UnitedHealth pays the highest dividend yield; UnitedHealth earns the most per share.
| MOH | UNH | |
|---|---|---|
| Snapshot | ||
| Sector | Healthcare Plans | Healthcare Plans |
| Last price | 198.39 | 339.85 |
| Change today | -2.43% | +2.84% |
| 1-year return | +47.5% | +11.3% |
| Market cap | $10.36B | $304.51B |
| 52-week range | 121.06 – 244.89 | 252.95 – 458.79 |
| Valuation | ||
| P/E (TTM) | -291.75 | 19.40 |
| P/E percentile, own 5-yr range | 0th | 41st |
| P/B | 2.49 | 3.10 |
| Dividend yield | 0.00% | 2.67% |
| Profitability & growth | ||
| EPS (TTM) | 8.92 | 13.23 |
| Net profit (TTM) | $465.62M | $11.85B |
| Revenue (TTM) | $44.13B | $449.66B |
| Provider revenue period date | 2026-09-29 | 2026-09-29 |
| Revenue growth (YoY) | -3.4% | -0.4% |
| Gross margin | 8.0% | 19.8% |
| Operating margin | 0.6% | 5.3% |
| Net margin | -0.1% | 3.5% |
| Free cash flow (TTM) | $238.00M | $22.83B |
| Provider cash-flow period date | 2026-09-29 | 2026-09-29 |
| Ownership & sentiment | ||
| Institutional ownership | 105.0% | 88.8% |
| Insider activity (12mo) | 35 buy / 14 sell | 44 buy / 5 sell |
| Short interest (% of float) | 5.6% | 1.6% |
| Analyst consensus | 29% buy / 57% hold / 14% sell (7) | 88% buy / 12% hold (17) |
| Analyst price target | $228 (+15%) | $485 (+43%) |
| StockVane view | ||
| StockVane Quant Rating | C (84) | D (55) |
| Company | ||
| Employees | 19,000 | 390,000 |
| Founded | 1980 | 1977 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.